Biodesix (NASDAQ:BDSX) Earns Sector Outperform Rating from Analysts at Scotiabank
Scotiabank assumed coverage on shares of Biodesix (NASDAQ:BDSX – Free Report) in a research note released on Monday, MarketBeat.com reports. The firm issued a sector outperform rating and a $3.00 target price on the stock. Separately, Craig Hallum started coverage on Biodesix in a report on Friday, July 26th. They set a buy rating and […]
19 Sep 06:00 · The Markets Daily